Two in five accredited specialty pharmacies are owned by hospitals and other healthcare providers, but the nation's three biggest pharmacy benefit managers accounted for 67% of specialty pharmacy revenue in 2023, according to Drug Channels.
Hospitals and health systems are the fastest-growing participants in this market, partly because of drugmakers' restrictions regarding the 340B program, the report said.
The top 15 specialty pharmacies, according to 2023 revenue:
1. CVS Specialty (CVS Health) — $73.3 billion
2. Accredo/Freedom Fertility (Cigna/Evernorth/Express Scripts) — $59.5 billion
3. Other retail, mail, long-term care and specialty pharmacies — $37.4 billion
4. Optum Specialty Pharmacy (UnitedHealthGroup/OptumRx) — $32.3 billion
5. AllianceRx Walgreens Pharmacy/Walgreens stores — $8.4 billion
6. CenterWell Specialty Pharmacy (Humana) — $6.2 billion
7. Onco360 Oncology Pharmacy/CareMed Specialty Pharmacy (BrightSpring Health Services) — $4.6 billion
8. PANTHERx Specialty Pharmacy — $3.6 billion
9. Walmart Specialty Pharmacy/Walmart stores — $3.4 billion
10. Kroger Specialty Pharmacy/Kroger stores — $3.2 billion
11. Acaria Health (Centene) — $2.9 billion
12. Biologics/RxCrossroads (McKesson) — $2.2 billion
13. SenderraRx — $2 billion
14. AHF Pharmacy (AIDS Healthcare Foundation) — $1.9 billion
15. Lumicera Health Services (Navitus Health Solutions) — $1.5 billion
Here is the ranking from 2022.